2021
DOI: 10.3390/pathogens10091112
|View full text |Cite
|
Sign up to set email alerts
|

“Chiclero’s Ulcer” Due to Leishmania mexicana in Travelers Returning from Central America: A Case Report and Review of the Literature

Abstract: Cutaneous leishmaniasis (CL) due to a New World species of Leishmania is increasingly seen among returning international travelers, and most cases arise from travel to Mexico, Central and South America. We described a case of CL in a women presenting a nonhealing ulceration under her right ear with slight increase of size of the left parotid gland under the skin lesion, evolving for 4 months. In her history of travel, she reported a ten-day stay in Mexico during the Christmas vacation in the Yucatan region wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Extended use and the decision to use a single dose of the drug in monotherapy has great public health benefits [40,41,141,142] but that policy must consider the fact that selection of AmB resistance is clearly feasible in both CL and VL species, as we have shown here with L. mexicana (CL) and L. infantum (VL), and that resistance can be sustained in parasites that are virulent in mammals. Although CL is mainly treated with antileishmanials other than AmB, the Pan American Health Organisation has suggested its use in relapse cases for New World cutaneous species [143] although several reports indicate that liposomal AmB was unsatisfactory in treating CL caused by L. mexicana [144][145][146].…”
Section: Discussionmentioning
confidence: 99%
“…Extended use and the decision to use a single dose of the drug in monotherapy has great public health benefits [40,41,141,142] but that policy must consider the fact that selection of AmB resistance is clearly feasible in both CL and VL species, as we have shown here with L. mexicana (CL) and L. infantum (VL), and that resistance can be sustained in parasites that are virulent in mammals. Although CL is mainly treated with antileishmanials other than AmB, the Pan American Health Organisation has suggested its use in relapse cases for New World cutaneous species [143] although several reports indicate that liposomal AmB was unsatisfactory in treating CL caused by L. mexicana [144][145][146].…”
Section: Discussionmentioning
confidence: 99%
“…Most of the CL caused by NW Leishmania species were presented as single lesions (79.0%; n = 290) and was preferentially located in the upper (41.2%) and lower (34.5%) limbs (Table 5). The head and neck regions were affected in 28.1% of cases (especially the ears-11/31, [69,93,122,128,129,159,162,177,189,194,228]). Patients frequently presented ulcerated lesions (77.2% of cases).…”
Section: Clinical Aspects and Management Of Cutaneous Leishmaniasismentioning
confidence: 99%